VSee Health, Inc. (VSEE) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	12.6M	14.6M	10.4M	5.8M	6.4M
Cost of Revenue	7.9M	7.3M	3.2M	1.9M	1.5M
Gross Profit	4.8M	7.4M	7.2M	3.8M	4.8M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	14.7M	16.9M	11.9M	5.4M	6.3M
General & Admin Expense	11.1M	9.9M	6.4M	719.1K	1.0M
Selling & Marketing Expense	3.6M	7.0M	5.4M	4.7M	5.3M
Other Expenses	97.0K	—	57.5M	326.6K	216.0K
Total Operating Expenses	14.8M	16.9M	69.3M	5.7M	6.5M
Cost and Expenses	22.6M	24.2M	72.6M	7.6M	8.1M
Operating Income (EBIT)	(10.0M)	(9.6M)	(62.2M)	(1.9M)	(1.7M)
Non-Operating
Interest Income	—	—	—	358.8K	922.6K
Interest Expense	1.8M	2.8M	211.5K	2.2M	126.0K
Net Interest Income	(1.8M)	(2.8M)	(211.5K)	(1.8M)	796.7K
Other Non-Op Income/Expense	(3.7M)	(5.1M)	2.8M	(13.4K)	59.9K
Non-Operating Income (excl Interest)	1.6M	2.2M	(57.5M)	(86.8K)	(216.0K)
EBT (Pre-Tax Income)	(13.8M)	(14.6M)	(59.3M)	(1.9M)	(1.6M)
Income Tax Expense	56.3K	68.4K	(1.6M)	1.8M	(694.4K)
Bottom Line
Net Income	(13.8M)	(14.7M)	(57.7M)	(3.8M)	(836.2K)
Earnings from Cont. Ops	(13.8M)	(14.7M)	(57.7M)	(3.7M)	(925.8K)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(13.8M)	(14.7M)	(57.7M)	(3.8M)	(836.2K)
Per Share
Basic EPS	($0.43)	($0.73)	($5.65)	($0.38)	($0.08)
Diluted EPS	($0.43)	($0.73)	($5.65)	($0.38)	($0.08)
Revenue Per Share	$0.24	$0.73	$1.02	$0.58	$0.64
Shares
Basic Shares Outstanding	53.7M	20.1M	10.2M	10.0M	10.0M
Diluted Shares Outstanding	53.7M	20.1M	10.2M	10.0M	10.0M
Profitability Metrics
EBITDA	(9.0M)	(9.2M)	(3.4M)	(1.8M)	—
D&A	2.6M	2.7M	1.3M	678.00	1.5M
EBIT	(11.6M)	(11.8M)	(4.7M)	(1.8M)	(1.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026